Transactivation through Ets and Ap1 transcription sites determines the expression of the tumor-suppressing gene Maspin

Cell Growth and Differentiation

Volumn 8, Issue 2, 1997, Pages 179-186

  Zhang, Ming ^a   Maass, Nicolai ^a,b   Magit, David ^a   Sager, Ruth ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

SERINE PROTEINASE INHIBITOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BREAST EPITHELIUM; ENZYME INHIBITION; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; IMMUNOHISTOCHEMISTRY; METASTASIS; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROMOTER REGION; SIGNAL TRANSDUCTION; TRANSACTIVATION; TUMOR SUPPRESSOR GENE;

ADAPTOR PROTEIN COMPLEX 1; ADAPTOR PROTEIN COMPLEX ALPHA SUBUNITS; ADAPTOR PROTEINS, VESICULAR TRANSPORT; BASE SEQUENCE; BLOTTING, NORTHERN; BREAST NEOPLASMS; CARCINOMA; CELL LINE; CLONING, MOLECULAR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; GENES, TUMOR SUPPRESSOR; HUMANS; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS (GENETICS); PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-ETS; SERINE PROTEINASE INHIBITORS; SERPINS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0031014764     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Liotta, L. A., Steeg, P. S., and Stetler-Stevenson, W. G. Cancer metastasis and angiogenesis: imbalance of positive and negative regulation. Cell, 64:327-336, 1991.
2. Zou, Z., Anisowicz, A., Hendrix, M. J. C., Thor, A., Neveu, M., Sheng, S., Rafidi, K., Seftor, E., and Sager, R. Identification of a novel serpin with tumor suppressing activity in human mammary epithelial cells. Science (Washington DC), 263: 526-529, 1994.
3. Sheng, S., Pemberton, P. A., and Sager, R. Production, purification and characterization of recombinant maspin proteins. J. Biol. Chem., 269: 30988-30993, 1995.
4. Sager, R., Sheng, S., Pemberton, P., and Hendrix, M. J. C. Maspin, a tumor suppressing serpin. Curr. Top. Microbiol, Immunol., 1: 51-64, 1995.
5. Curren, T., and Franza, B. R. Fos and Jun: the AP-1 connection. Cell, 55:395-397, 1988.
6. Macleod, K., Leprince, D., and Stehelin, D. The Ets gene family. Trends Biochem. Sci., 17: 252-256, 1992.
7. Wasylyk, B., Hahn, S. L., and Giovane, A. The ETS family of transcription factors. Eur. J. Biochem., 211: 7-18, 1993.
8. Wasylyk, C., Flores, P., Gutman, A., and Wasylyk, B. PEA3 is a nuclear target for transcription activation by non-nuclear oncogenes. EMBO J., 8: 3371-3378, 1989.
9. Trimble, M., Xin, J., Guy, C. T., Muller, W., and Hassell, J. PEA3 is overexpressed in mouse mammary adenocarcinomas. Oncogene, 8: 3037-3042, 1993.
10. Kaya, M., Yoshida, K., Higashino, F., Mitaka, T., Ishii, S., and Fujinaga, K. A single ETS-related transcription factor, E1AF, confers invasive phenotype on human cancer cells. Oncogene, 12: 221-227, 1996.
11. Gutman, A., and Wasylyk, B. The collagenase gene promoter contains a TPA and oncogene-responsive unit encompassing the PEA3 and AP-1 binding sites. EMBO J., 9: 2241-2246, 1990.
12. Buttice, G., and Kurkinen, M. A polyomavirus enhancer A-binding protein-3 site and ETS-2 protein have a major role in the 12-O- tetradecanoylphorbol-13-acetate response of the human stromelysin gene. J. Biol. Chem., 268: 7169-7204, 1993.
13. Boccia, L. M., Lillicrap, D., Newcombe, K., and Mueller, C. R. Binding of the ETS factor GA-binding protein to an upstream site in the factor IX promoter is a critical event in transcription. Mol. Cell. Biol., 16: 1929-1935, 1996.
14. Nerlov, C., Rorth, P., Blasi, F., and Johnsen, M. Essential AP-1 and PEA3 binding elements in the human urokinase enhancer display cell type- specific activity. Oncogene, 6: 1583-1592, 1991.
15. Nerlov, C., Cesare, D., Pergola, F., Caracciolo, A., Blasi, F., Johnsen, M., and Verde, P. A regulatory element that mediates co-operation between a PEA3-AP1 element and an AP-1 site is required for phorbol ester induction of urokinase enhancer activity in HepG2 hepatoma cells. EMBO J., 11: 4573-4582, 1992.
16. Wargnier, A., Legros-Maida, S., Bosselut, R., Bourge, J. F., Lafaurie, C., Ghysdael, C. J., Saportes, M., and Paul, P. Identification of human granzyme B promoter regulatory elements interacting with activated T-cell-specific proteins: implication of Ikaros and CBF binding sites in promoter activation. Proc. Natl. Acad. Sci. USA, 92: 6930-6934, 1995.
17. Duffy, M., Reilly, D. C., O'Sullivan, C., O'Higgins, N., Fennelly, J., and Andreasen, P. A. Urokinase-plasminogen activator, a new and independent prognostic marker in breast cancer. Cancer Res., 50: 6827-6829, 1990.
18. Sappino, A. P., Busso, N., Belin, D., and Vassali, J. D. Increase of urokinase type plasminogen activator gene expression in human lung and breast carcinomas. Cancer Res., 47: 4043-4046, 1987.
19. Nakajima, M., Lotan, D., Baig, M., Carralero, R. M., Wood, W. R., Hendrix, M. J. C., and Lotan, R. Inhibition of retinoic acid of type IV collagenolysis and invasion through reconstituted basement membrane by metastatic rat mammary adenocarcinoma cells. Cancer Res., 49: 1698-1706, 1989.
20. Wasylyk, C., and Wasylyk, B. Oncogenic conversion alters the transcriptional properties of ETS. Cell Growth & Differ., 3: 617-625, 1992.
21. Topper, T. J., and Freeman, C. S. Multiple hormone interactions in the developmental biology of the mammary gland. Mol. Cell. Biol., 12: 4906-4918, 1992.
22. Mink, S., Hartig, E., Jennewein, P., Doppler, W., and Cato, A. A mammary cell-specific enhancer in mouse mammary tumor virus DNA is composed of multiple regulatory elements including binding sites for CTF/NFI and a novel transcription factor, mammary cell-activating factor. Mol. Cell. Biol., 12: 4906-4918, 1991.
23. Werner, M. H., Clore, G. M., Fisher, C. L., Fisher, R. J., Trich, L., Shiloach, J., and Gronenborn, A. M. The solution structure of the human ETS1-DNA complex reveals a novel mode of binding and true side chain interaction. Cell, 83: 761-771, 1995.
24. Wasylyk, B., Wasylyk, C., Flores, P., Begue, A., Leprince, D., and Stehelin, D. The c-ets proto-oncogenes encode transcription factors that cooperate with c-Fos and c-Jun for transeriptional activation. Nature (Lond.), 346: 191-193, 1990.
25. Weite, T., Garimorth, K., Philip, S., Jennewein, P., Huck, C., Cato, A., and Doppler, W. Involvement of Ets-related proteins in hormone- independent mammary cell-specific gene expression. Eur. J. Biochem., 997-1006, 1994.
26. Petersen, J. M., Skalicky, J. J., Donaldson, L. W., Mclntosh, L. P., Alber, T., and Graves, B. J. Modulation of transcription factor Ets-1 DNA binding: DNA-induced unfolding of an α helix. Science (Washington DC), 269: 1866-1869, 1995.
27. Treier, M., Bohmann, D., and Mlodzik, M. Jun cooperates with the ETS domain protein Pointed to induce photoreceptor R7 fate in the Drosophila eye. Cell, 83: 753-760, 1995.
28. Sager, R., Sheng, S., Anisowicz, A., Sotiropoulou, G., Zou, Z., Steman, G., Swisshelm, K., Chen, Z., Hendrix, M. J. C., Pemberton, P., Rafidi, K., and Ryan, K. RNA genetics of breast cancer: maspin as paradigm. Cold Spring Harbor Symp. Quant. BioL, 59: 537-546, 1994.
29. Schneider, S. S., Schick, C., Fish, K. E., Miller, E. Pena, J. C., Treter, S. D., Hui, S. M., and Silverman, G. A. A serine proteinase inhibitor locus at 18q21.3 contains a tandem duplication of the human squamous cell carcinoma antigen gene. Proc. Natl. Acad. Sci. USA, 92: 3147-3151, 1995.
30. Band, V., and Sager, R. Distinctive traits of normal and tumor derived human mammary epithelial cells expressed in a medium that supports long-term growth of both cell types. Proc. Natl. Acad. Sci. USA, 86: 1249-1253, 1989.
31. Band, V., Zajchowski, D., Stenman, G., Morton, C., Kulesa, V., Connolly, J., and Sager, R. A newly established metastatic breast tumor cell line with integrated amplified copies of ERBB2 and double minute chromosomes. Genes Chromosomes Cancer, 1: 48-58, 1989.
32. Swisshelm, K., Ryan, K., Lee, X., Tsou, H. C., Peacocke, M., and Sager, R. Down-regulation of retinoic acid receptor b in mammary carcinoma cell lines and its up-regulation in senescing normal mammary epithelial cells. Cell Growth & Differ., 5: 133-141, 1994.
33. Laborda, J. 36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO. Nucleic Acids Res., 19: 3998, 1991.
34. Luckow, B., and Schutz, G. CAT constructs with multiple unique restriction sites for the functional analysis of eukaryotic promoters and regulatoty elements. Nucleic Acids Res., 15: 5490, 1987.
35. Sassone-Corsi, P., and Verma, I. M. Modulation of c-fos gene transcription by negative and positive cellular factors. Nature (Lond.), 326: 507.
36. Gorman, C. M., Moffat, L. F., and Howard, B. H. Recombinant genomes which expressed chloramphenicol acetyl transferase in mammalian cells. Mol. Gel. Biol., 2: 1044-1057, 1982.